Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s share price rose 18.4% during mid-day trading on Tuesday . The stock traded as high as GBX 1.90 ($0.02) and last traded at GBX 1.90 ($0.02). Approximately 4,184,618 shares traded hands during mid-day trading, an increase of 135% from the average daily volume of 1,782,671 shares. The stock had previously closed at GBX 1.60 ($0.02).
Cizzle Biotechnology Trading Up 18.4 %
The stock has a 50-day simple moving average of GBX 1.80 and a 200 day simple moving average of GBX 1.85. The stock has a market capitalization of £7.51 million, a price-to-earnings ratio of -189.50 and a beta of 0.38.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Featured Articles
- Five stocks we like better than Cizzle Biotechnology
- What is a Special Dividend?
- NVIDIA is Still the Most Important Stock in the Market
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 2 Gene-Editing Stocks Positioned for a Strong Comeback in 2025
- Canada Bond Market Holiday: How to Invest and Trade
- Will Berkshire Hathaway Continue to Dominate in 2025?
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
